Skip to main content
Log in

Hematuria and proteinuria in a 14-year-old boy on anti-tubercular treatment: Answers

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 366:1119–1131

    Article  CAS  Google Scholar 

  2. Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D’Agati VD, Appel GB (2018) C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney Int 93:977–985

    Article  Google Scholar 

  3. Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70:246–256

    Article  CAS  Google Scholar 

  4. Pretel M, Marquès L, España A (2014) Drug-induced lupus erythematosus. Actas Dermosifiliogr 105:18–30

    Article  CAS  Google Scholar 

  5. Uppsala Monitoring Center. The use of the WHO-UMC system for standardised case causality assessment. https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf. Accessed 25 Jan 2022

  6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    Article  CAS  Google Scholar 

  7. Cerqueira A, Seco T, Paiva D, Martins H, Cotter J (2020) Isoniazid-induced lupus: when the cure can be lethal. Cureus 12:7311

    Google Scholar 

  8. Vasoo S (2006) Drug-induced lupus: an update. Lupus 15:757–761

    Article  CAS  Google Scholar 

  9. Timmins G, Deretic V (2006) Mechanisms of action of isoniazid. Mol Microbiol 62:1220–1227

    Article  CAS  Google Scholar 

  10. Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY, Chang FY, Lee SD (2002) Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology 35:883–889

    Article  CAS  Google Scholar 

  11. Berning SE, Iseman MD (1997) Rifamycin-induced lupus syndrome. Lancet 349:1521

    Article  CAS  Google Scholar 

  12. Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Rheum Ann Dis 78:736–745

    Article  CAS  Google Scholar 

  13. Hoffman BJ (1945) Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus. Arch Dermatol Syphilol 51:190–192

    Article  Google Scholar 

  14. Borchers AT, Keen CL, Gershwin ME (2007) Drug-induced lupus. Ann N Y Acad Sci 1108:166–182

    Article  CAS  Google Scholar 

  15. He Y, Sawalha AH (2018) Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr Opin Rheumatol 30:490–497

    Article  CAS  Google Scholar 

  16. Alarcon-Segovia D, Fishbein E, Alcala H (1971) Isoniazid acetylation rate and development of antinuclear antibodies upon isoniazid treatment. Arthritis Rheum 14:748–752

    Article  CAS  Google Scholar 

  17. Batchelor JR, Welsh KI, Tinoco RM, Dollery CT, Hughes GR, Bernstein R, Ryan P, Naish PF, Aber GM, Bing RF, Russell GI (1980) Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet 1:1107–1109

    Article  CAS  Google Scholar 

  18. Irizarry-Caro JA, Carmona-Rivera C, Schwartz DM, Khaznadar SS, Kaplan MJ, Grayson PC (2018) Brief report: drugs implicated in systemic autoimmunity modulate neutrophil extracellular trap formation. Arthritis Rheumatol 70:468–474

    Article  CAS  Google Scholar 

  19. Hogan JJ, Markowitz GS, Radhakrishnan J (2015) Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol 10:1300–1310

    Article  CAS  Google Scholar 

  20. Vaglio A, Grayson PC, Fenaroli P (2018) Drug-induced lupus: traditional and new concepts. Autoimmun Rev 17:912

    Article  CAS  Google Scholar 

  21. Luwanda LB, Gamell A (2018) Isoniazid-induced subacute cutaneous lupus erythematosus in an HIV-positive woman: a rare side effect to be aware of with the current expansion of isoniazid preventive therapy. Pan Afr Med J 29:200

    Article  Google Scholar 

  22. Khattri S, Kushawaha A, Dahal K, Lee M, Mobarakai N (2011) Isoniazid (INH)-induced eosinophilic exudative pleural effusion and lupus erythematosus. A clinical reminder of drug side effects. Bull NYU Hosp Jt Dis 69:181–184

    PubMed  Google Scholar 

  23. Rakotoson JL, Randriamanana D, Rakotomizao JR, Andrianasolo R, Rakotoarivelo R, Andrianarisoa AC (2009) Severe systemic lupus erythematosus induced by isoniazide. Rev Pneumol Clin 65:361–364

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Sanjana Sarangarajan, Sriram Krishnamurthy, Bobbity Deepthi, and Aswini Annadurai managed the patient, reviewed the literature, and drafted the manuscript. Sriram Krishnamurthy reviewed the literature and critically revised the manuscript. Bheemanathi Hanuman Srinivas interpreted the histopathological findings. All authors contributed to the review of literature, drafting of the manuscript, and approved the final version of the manuscript. Sriram Krishnamurthy shall act as the guarantor of the paper.

Corresponding author

Correspondence to Sriram Krishnamurthy.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This refers to the article that can be found at http://dx.doi.org/10.1007/s00467-022-05435-2.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sarangarajan, S., Krishnamurthy, S., Deepthi, B. et al. Hematuria and proteinuria in a 14-year-old boy on anti-tubercular treatment: Answers. Pediatr Nephrol 37, 1541–1545 (2022). https://doi.org/10.1007/s00467-022-05462-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-022-05462-z

Keywords

Navigation